Tag Archives: Pfizer

President Donald Trump is expected to announce on Tuesday a multipronged effort aimed at lowering drug costs in the United States, including the creation of a “TrumpRx” direct-to-consumer website where Americans can buy medicine at discounted prices and a deal with Pfizer to reduce the cost of its medications, sources familiar with the matter told CNN. Details of the deal …

Washington — Pfizer has agreed to offer significantly discounted prices for some prescription drugs for all American consumers and has committed to offer prescription medications to Medicaid at lower prices, President Trump announced Tuesday. The president said the drugs will be available for purchase online on a website operated by the federal government, which the White House has said will …

Exclusive | White House to Announce ‘TrumpRx’ Drug-Buying Website, and Deal With Pfizer  The Wall Street Journal Trump, Pfizer to announce agreement to lower drug prices  CNBC Trump to announce drug-pricing deal with Pfizer  The Washington Post Trump and Big Pharma at loggerheads over drug prices  Axios The Trump administration’s favored tactic to force companies to act  Politico Source link

The drugmaker Pfizer faces a US lawsuit brought on behalf of women who developed brain tumours, which they say are linked to their use of the company’s contraceptive injection Depo-Provera. The class action lawsuit alleges that the US pharmaceutical company failed to warn women and doctors about an increased risk of developing an intracranial meningioma if Depo-Provera, a quarterly injection, …

Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera share in cash upon closing, for an initial enterprise value of $4.9 billion with a CVR of up to $22.50 per share in additional payments Pfizer to host a public webcast at 8 am EDT today NEW YORK–(BUSINESS WIRE)– …

Pfizer has acquired Metsera for $4.9bn, as the drugmaker targets longer-lasting glucagon-like peptide-1 receptor agonists (GLP-1RAs) to cement market share in the burgeoning weight loss treatment sector. Pfizer has agreed to buy all of Metsera’s shares for a price of $47.50 each, representing a 43% premium to Metsera’s closing share price of $33.32 on 19 September. The deal, forecast to …

Fox, Coinbase, Metsera, Pfizer, Kenvue, Anywhere Real Estate, Premier, and More Movers  Barron’s Stocks making the biggest premarket moves: Metsera, Compass, Kenvue, Fox & more  CNBC Stocks to Watch Monday: Fox, Compass, Infosys, Metsera  The Wall Street Journal Fox, Snap and ASML rise premarket; Kenvue and Coinbase fall  Investing.com These Stocks Are Moving the Most Today: Fox, Coinbase, Metsera, Pfizer, Kenvue, Tesla, and More  MSN …

Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion  The Wall Street Journal Pfizer expands obesity drug pipeline with $7.3 billion deal to buy Metsera  CNBC Pfizer goes full speed ahead on obesity with $4.9B acquisition of Metsera  Endpoints News Pfizer to buy Metsera for up to $7.3B  Axios Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion  Yahoo …

Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports  ReutersView Full Coverage on Google News Source link

A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois, Dec. 30, 2021. Brian Cassella | Tribune News Service | Getty Images The Food and Drug Administration is weighing revoking its authorization of Pfizer‘s Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed to CNBC on …